Stroke: secondary prevention

Overview

Prevention in this context is the long-term management of people with previous stroke or transient ischaemic attack (TIA), and of people at high risk of stroke for other reasons such as atrial fibrillation. Stroke: Stroke is characterised by rapidly developing clinical symptoms and signs of focal, and at times global, loss of cerebral function lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin. Ischaemic stroke is stroke caused by vascular insufficiency (such as cerebrovascular thromboembolism) rather than by haemorrhage. TIA: This is similar to a mild ischaemic stroke, except that symptoms last for less than 24 hours.[1] For management of stroke in the acute phase, see review on stroke management.

Latest citations

The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. ( 17 December 2014 )

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial. ( 17 December 2014 )